Novozymes A/S/DKrNSIS B
08:00
10:00
12:00
13:55
15:55
1D1W1MYTD1Y5YMAX
About Novozymes A/S
Ticker
DKrNSIS B
Sector
Primary listing
CSE
Employees
10,582
Headquarters
Lyngby, Denmark
Website
Novozymes A/S Metrics
BasicAdvanced
kr 182B
26.43
kr 14.87
0.55
kr 6.45
1.64%
Price and volume
Market cap
kr 182B
Beta
0.55
52-week high
kr 414.50
52-week low
kr 374.80
Average daily volume
577K
Dividend rate
kr 6.45
Financial strength
Current ratio
1.752
Quick ratio
1.038
Long term debt to equity
27.69
Total debt to equity
30.92
Dividend payout ratio (TTM)
68.57%
Interest coverage (TTM)
15.48%
Profitability
EBITDA (TTM)
10,350.345
Gross margin (TTM)
57.72%
Net profit margin (TTM)
13.78%
Operating margin (TTM)
27.21%
Effective tax rate (TTM)
24.33%
Revenue per employee (TTM)
kr 2,912,640
Management effectiveness
Return on assets (TTM)
4.40%
Return on equity (TTM)
5.19%
Valuation
Price to earnings (TTM)
26.434
Price to revenue (TTM)
3.643
Price to book
16.98
Price to tangible book (TTM)
-392.89
Price to free cash flow (TTM)
26.244
Free cash flow yield (TTM)
3.81%
Free cash flow per share (TTM)
14.979
Dividend yield (TTM)
1.64%
Growth
Revenue change (TTM)
34.50%
Earnings per share change (TTM)
158.40%
3-year revenue growth (CAGR)
23.44%
10-year revenue growth (CAGR)
8.60%
3-year earnings per share growth (CAGR)
10.14%
10-year earnings per share growth (CAGR)
5.82%
3-year dividend per share growth (CAGR)
5.27%
10-year dividend per share growth (CAGR)
7.90%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Novozymes A/S stock?
Novozymes A/S (NSIS B) has a market cap of DKr182B as of October 29, 2025.
What is the P/E ratio for Novozymes A/S stock?
The price to earnings (P/E) ratio for Novozymes A/S (NSIS B) stock is 26.43 as of October 29, 2025.
Does Novozymes A/S stock pay dividends?
Yes, the Novozymes A/S (NSIS B) stock pays dividends to shareholders. As of October 29, 2025, the dividend rate is DKr6.45 and the yield is 1.64%. Novozymes A/S has a payout ratio of 68.57% on a trailing twelve-month basis.
When is the next Novozymes A/S dividend payment date?
The next Novozymes A/S (NSIS B) dividend payment date is unconfirmed.
What is the beta indicator for Novozymes A/S?
Novozymes A/S (NSIS B) has a beta rating of 0.55. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.